share_log

Truist Securities Initiates Coverage On Insmed With Buy Rating, Announces Price Target of $48

Moomoo 24/7 ·  Apr 23 06:40

Truist Securities analyst Nicole Germino initiates coverage on Insmed (NASDAQ:INSM) with a Buy rating and announces Price Target of $48.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment